Tudor Investment Corp’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-17,554
| Closed | -$118K | – | 2125 |
|
|
2022
Q3 | $118K | Sell |
17,554
-28,134
| -62% | -$189K | ﹤0.01% | 1468 |
|
|
2022
Q2 | $192K | Hold |
45,688
| – | – | 0.01% | 1383 |
|
|
2022
Q1 | $154K | Hold |
45,688
| – | – | ﹤0.01% | 1409 |
|
|
2021
Q4 | $144K | Sell |
45,688
-34,144
| -43% | -$108K | ﹤0.01% | 1502 |
|
|
2021
Q3 | $261K | Buy |
79,832
+8,917
| +13% | +$29.2K | ﹤0.01% | 1351 |
|
|
2021
Q2 | $299K | Sell |
70,915
-9,277
| -12% | -$39.1K | 0.01% | 1269 |
|
|
2021
Q1 | $400K | Buy |
+80,192
| New | +$400K | 0.01% | 1200 |
|
|
2019
Q4 | – | Sell |
-20,898
| Closed | -$123K | – | 1432 |
|
|
2019
Q3 | $123K | Buy |
20,898
+1,838
| +10% | +$10.8K | ﹤0.01% | 978 |
|
|
2019
Q2 | $229K | Buy |
+19,060
| New | +$229K | 0.01% | 926 |
|
|
2018
Q2 | – | Sell |
-19,290
| Closed | -$442K | – | 1266 |
|
|
2018
Q1 | $442K | Buy |
+19,290
| New | +$442K | 0.01% | 597 |
|
|
2016
Q4 | – | Sell |
-11,507
| Closed | -$116K | – | 1645 |
|
|
2016
Q3 | $116K | Sell |
11,507
-1,075
| -9% | -$10.8K | ﹤0.01% | 1308 |
|
|
2016
Q2 | $141K | Sell |
12,582
-700
| -5% | -$7.85K | ﹤0.01% | 1306 |
|
|
2016
Q1 | $181K | Buy |
+13,282
| New | +$181K | ﹤0.01% | 1288 |
|
|
2015
Q2 | – | Sell |
-51,025
| Closed | -$773K | – | 1683 |
|
|
2015
Q1 | $773K | Buy |
+51,025
| New | +$773K | 0.02% | 479 |
|